drugset / Trial / NCT03805750

Trial of Cannabis for Essential Tremor

NCT03805750

RandomizedCrossoverQuadruple-blindTreatment

Summary

This is a pilot trial to evaluate the safety and efficacy of a combined oral formulation of THC and CBD in patients with Essential Tremor.

Timeline

Start
2019-01-22
Primary completion
2020-09-01
Completion
2020-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 100 mg Oral
Subject Dronabinol Other / unclassified 5 mg Oral

Indications